Treatmentemerging

NMN Oral Supplement Program

Clinic-dispensed oral nicotinamide mononucleotide (capsules, sublingual tablets or powder, commonly 250-1000 mg/day) sold as a NAD+-precursor longevity supplement, often bundled into a subscription or monitored protocol.

Evidence

emerging

Human RCTs consistently show oral NMN raises blood NAD+ and is well tolerated, but functional/longevity outcomes are mixed and often null (e.g. a 2025 meta-analysis found no muscle or physical-function benefit), so the longevity claim is only weakly supported.

Regulatory notes

European Union
NMN is not authorised as a Novel Food in the EU, so it cannot legally be sold as a food supplement; clinic sale sits in a gray area and is technically non-compliant for ingestion claims.
United States
After excluding NMN in 2022, the FDA reversed course in 2025 and treats NMN as lawful in dietary supplements via the NDI pathway; sold as a supplement, not an approved drug, with no permitted disease claims.
United Arab Emirates
Sold as a supplement subject to MoHAP/Dubai Municipality registration; permitted health claims are limited and no longevity claim is approved.
United Kingdom
Sold as a food supplement post-Brexit but without authorised health claims; longevity marketing claims are not permitted.

General information, not medical or legal advice. See our disclaimer.

Also known as

NMN, beta-NMN, nicotinamide mononucleotide, NMN capsules, sublingual NMN, NMN powder, MIB-626

Where to find it

43 clinics in the directory offer nmn oral supplement program. Prices shown are the cheapest for this treatment where published; always confirm with the venue.

Back to glossary